InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by Dahms Bradford D., Chief Financial Officer. Officer active across 1 companies, notably Theseus Pharmaceuticals, Inc.. Aggregated, 2 reports have been recorded. Total volume traded: €35k. The latest transaction was filed on 21 December 2021 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations2 total
€17,7341,970.036 shares@ €9.0021100.0% of flow
Common Stock
SEC:0000899243-21-049427·
Ideal exit: 17 Sept 2022 (T+270)
€17,7341,970.036 shares@ €9.002150.0% of flow
Common Stock
SEC:0000899243-21-049427:0·
Ideal exit: 17 Sept 2022 (T+270)
2 of 2 declarations
About Dahms Bradford D.
Bradford D. Dahms serves as Chief Financial Officer at Theseus Pharmaceuticals, Inc. In this role, he oversees the company's financial operations, including financial planning and reporting. Bradford has significant experience in finance, enabling him to contribute to the company's financial strategy. His analytical approach is essential for navigating a complex financial environment.
